TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord

Acta Neuropathologica

Volumn 128, Issue 3, 2014, Pages 423-437

  Brettschneider, Johannes ^b   Arai, Kimihito ^c,d   Del Tredici, Kelly ^a   Toledo, Jon B ^b   Robinson, John L ^b   Lee, Edward B ^b   Kuwabara, Satoshi ^d   Shibuya, Kazumoto ^d   Irwin, David J ^b   Fang, Lubin ^a   Van Deerlin, Vivianna M ^b   Elman, Lauren ^b   McCluskey, Leo ^b   Ludolph, Albert C ^a   Lee, Virginia M Y ^b   Braak, Heiko ^a   Trojanowski, John Q ^b  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c SAKURA NATIONAL HOSPITAL   (Japan)

^d CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Neurodegeneration; Oligodendroglia; Onuf's nucleus; Spinal cord; TDP 43

Indexed keywords

TAR DNA BINDING PROTEIN; ALPHA SYNUCLEIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CLAUDIN; CLDN11 PROTEIN, HUMAN; DNA BINDING PROTEIN; NERVE PROTEIN; OLIG2 PROTEIN, HUMAN; PROTEIN TDP-43; TAU PROTEIN;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARM; ARTICLE; AUTOPSY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC ANALYSIS; GRAY MATTER; HUMAN; HUMAN TISSUE; LEG; MALE; MESENCEPHALON; MIDDLE AGED; NERVE CELL; NERVE CELL LESION; OCULOMOTOR NUCLEUS; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PHOSPHORYLATION; SPINAL CORD; TDP 43 PROTEINOPATHY; VERY ELDERLY; WHITE MATTER; CASE CONTROL STUDY; CELL DEATH; COHORT ANALYSIS; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PHYSIOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; AMYOTROPHIC LATERAL SCLEROSIS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; CELL DEATH; CLAUDINS; COHORT STUDIES; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONS; SPINAL CORD; STATISTICS, NONPARAMETRIC; TAU PROTEINS;

EID: 84906314307     PISSN: 00016322     EISSN: 14320533     Source Type: Journal    
DOI: 10.1007/s00401-014-1299-6     Document Type: Article

References (63)

1. Braak H, Alafuzoff I, Arzberger T et al (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404 (Pubitemid 44469160)
2. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
3. Braak H, Brettschneider J, Ludolph AC et al (2013) Amyotrophic lateral sclerosis-a model of corticofugal axonal spread. Nat Rev Neurol 9:708-714
4. Braak H, Del Tredici K (2011) The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol 121:171-181
5. Braak H, Del Tredici K (2012) Where, when, and in what form does sporadic Alzheimer's disease begin? Curr Opin Neurol 25:708-714
6. Braak H, Del Tredici K, Rüb U et al (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211 (Pubitemid 36007810)
7. Braak H, Ludolph A, Thal DR et al (2010) Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord. Acta Neuropathol 120:67-74
8. Brettschneider J, Del Tredici K, Irwin DJ et al (2014) Sequential distribution of pTDP-43 pathology in behavioral variant fronto-temporal dementia (bvFTD). Acta Neuropathol 127:423-439
9. Brettschneider J, Del Tredici K, Toledo JB et al (2013) Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol 74:20-38
10. Brettschneider J, Libon DJ, Toledo JB et al (2012) Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol 123:395-407
11. Brettschneider J, Toledo JB, Van Deerlin VM et al (2012) Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS One 7:e39216
12. Brettschneider J, Van Deerlin VM, Robinson JL et al (2012) Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol 123:825-839
13. Brooks BR, Miller RG, Swash M et al (2000) El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1:293-299
14. Brown LT (1974) Rubrospinal projections in the rat. J Comp Neurol 154:169-187
15. Cedarbaum JM, Stambler N, Malta E et al (1999) The ALSFRSR: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III). J Neurol Sci 169:13-21 (Pubitemid 29502501)
16. Cooper-Knock J, Hewitt C, Highley JR et al (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135:751-764
17. Donaghy C, Thurtell MJ, Pioro EP et al (2011) Eye movements in amyotrophic lateral sclerosis and its mimics: a review with illustrative cases. J Neurol Neurosurg Psychiatry 82:110-116
18. Duda JE, Giasson BI, Mabon ME et al (2002) Novel antibodies to synuclein show abundant striatal pathology in Lewy body diseases. Ann Neurol 52:205-210 (Pubitemid 34810601)
19. Fallini C, Bassell GJ, Rossoll W (2012) The ALS disease protein TDP-43 is actively transported in motor neuron axons and regulates axon outgrowth. Hum Mol Genet 21:3703-3718
20. Feldengut S, Del Tredici K, Braak H (2013) Paraffin sections of 70-100 mum: a novel technique and its benefits for studying the nervous system. J Neurosci Methods 215:241-244
21. .Geser F, Brandmeir NJ, Kwong LK et al (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Arch Neurol 65:636-641 (Pubitemid 351679659)
22. .Geser F, Martinez-Lage M, Robinson J et al (2009) Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol 66:180-189
23. .Guo JL, Lee VM (2014) Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases. Nat Med 20:130-138
24. Harvey DG, Torack RM, Rosenbaum HE (1979) Amyotrophic lateral sclerosis with ophthalmoplegia. A clinicopathologic study. Arch Neurol 36:615-617 (Pubitemid 9247534)
25. Horner PJ, Thallmair M, Gage FH (2002) Defining the NG2- expressing cell of the adult CNS. J Neurocytol 31:469-480 (Pubitemid 37378259)
26. Iwanaga K, Hayashi S, Oyake M et al (1997) Neuropathology of sporadic amyotrophic lateral sclerosis of long duration. J Neurol Sci 146:139-143 (Pubitemid 27112833)
27. Jenny AB, Inukai J (1983) Principles of motor organization of the monkey cervical spinal cord. J Neurosci 3:567-575 (Pubitemid 13132721)
28. Jucker M, Walker LC (2013) Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 501:45-51
29. Kang SH, Li Y, Fukaya M et al (2013) Degeneration and impaired regeneration of gray matter oligodendrocytes in amyotrophic lateral sclerosis. Nat Neurosci 16:571-579
30. Keller BA, Volkening K, Droppelmann CA et al (2012) Coaggregation of RNA binding proteins in ALS spinal motor neurons: evidence of a common pathogenic mechanism. Acta Neuropathol 124:733-747
31. Kiernan MC, Vucic S, Cheah BC et al (2011) Amyotrophic lateral sclerosis. Lancet 377:942-955
32. Kimura T, Jiang H, Konno T et al. (2014) Bunina bodies in motor and non-motor neurons revisited: a pathological study of an ALS patient after long-term survival on a respirator. Neuropathology
33. Komachi H, Okeda R, Ishii N et al (1994) Motor neuron disease with dementia and ophthalmoplegia. A clinical and pathological study. J Neurol 241:592-596 (Pubitemid 24309916)
34. Lee EB, Lee VM, Trojanowski JQ (2012) Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 13:38-50
35. Lee EB, Leng LZ, Zhang B et al (2006) Targeting amyloid-beta peptide (Abeta) oligomers by passive immunization with a conformation-selective monoclonal antibody improves learning and memory in Abeta precursor protein (APP) transgenic mice. J Biol Chem 281:4292-4299 (Pubitemid 43847859)
36. Lee Y, Morrison BM, Li Y et al (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487:443-448
37. Ling SC, Polymenidou M, Cleveland DW (2013) Converging mechanisms in ALS and FTD: disrupted RNA and protein homeostasis. Neuron 79:416-438
38. Miki Y, Mori F, Nunomura J et al (2010) Sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration: a TDP- 43 immunohistochemical study. Neuropathology 30:149-153
39. Mizuno Y, Fujita Y, Takatama M et al (2012) Comparison of phosphorylated TDP-43-positive inclusions in oculomotor neurons in patients with non-ALS and ALS disorders. J Neurol Sci 315:20-25
40. Mori F, Tanji K, Zhang HX et al (2008) Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 116:193-203
41. Neumann M, Sampathu DM, Kwong LK et al (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314:130-133 (Pubitemid 44547757)
42. Nishihira Y, Tan CF, Hoshi Y et al (2009) Sporadic amyotrophic lateral sclerosis of long duration is associated with relatively mild TDP-43 pathology. Acta Neuropathol 117:45-53
43. Nishihira Y, Tan CF, Onodera O et al (2008) Sporadic amyotrophic lateral sclerosis: two pathological patterns shown by analysis of distribution of TDP-43-immunoreactive neuronal and glial cytoplasmic inclusions. Acta Neuropathol 116:169-182
44. Nonaka T, Masuda-Suzukake M, Arai T et al (2013) Prion-like properties of pathological TDP-43 aggregates from diseased brains. Cell Rep 4:124-134
45. Phukan J, Pender NP, Hardiman O (2007) Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol 6:994-1003 (Pubitemid 47562321)
46. Ravits J, Paul P, Jorg C (2007) Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68:1571-1575 (Pubitemid 46717980)
47. Ravits JM, La Spada AR (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73:805-811
48. Rexed B (1954) A cytoarchitectonic atlas of the spinal cord in the cat. J Comp Neurol 100:297-379
49. Riku Y, Watanabe H, Yoshida M et al (2014) Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis. JAMA Neurol 71:172-179
50. Routal RV, Pal GP (1999) A study of motoneuron groups and motor columns of the human spinal cord. J Anat 195(Pt 2):211-224 (Pubitemid 29452880)
51. Rowland LP (2001) How amyotrophic lateral sclerosis got its name: the clinical-pathologic genius of Jean-Martin Charcot. Arch Neurol 58:512-515
52. Schoenen J (1982) Dendritic organization of the human spinal cord: the motoneurons. J Comp Neurol 211:226-247
53. Sharrard WJ (1955) The distribution of the permanent paralysis in the lower limb in poliomyelitis: a clinical and pathological study. J Bone Jt Surg Br 37-B:540-558
54. Stewart H, Rutherford NJ, Briemberg H et al (2012) Clinical and pathological features of amyotrophic lateral sclerosis caused by mutation in the C9ORF72 gene on chromosome 9p. Acta Neuropathol 123:409-417
55. Sumi H, Kato S, Mochimaru Y et al (2009) Nuclear TAR DNA binding protein 43 expression in spinal cord neurons correlates with the clinical course in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 68:37-47
56. Takeda T, Uchihara T, Nakayama Y et al (2014) Dendritic retraction, but not atrophy, is consistent in amyotrophic lateral sclerosis- comparison between Onuf's neurons and other sacral motor neurons. Acta Neuropathol Commun 2:11
57. Terman JR, Wang XM, Martin GF (1998) Origin, course, and laterality of spinocerebellar axons in the North American opossum, Didelphis virginiana. Anat Rec 251:528-547 (Pubitemid 28366725)
58. Thal DR, Rub U, Orantes M et al (2002) Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 58:1791-1800 (Pubitemid 34663580)
59. Toledo JB, Van Deerlin VM, Lee EB et al (2013) A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimers Dement
60. Van Rheenen W, Van Blitterswijk M, Huisman MH et al (2012) Hexanucleotide repeat expansions in C9ORF72 in the spectrum of motor neuron diseases. Neurology 79:878-882
61. Waldron HA, Gwyn DG (1969) Descending nerve tracts in the spinal cord of the rat. I. Fibers from the midbrain. J Comp Neurol 137:143-153
62. Xie SX, Baek Y, Grossman M et al (2011) Building an integrated neurodegenerative disease database at an academic health center. Alzheimers Dement 7:e84-e93
63. Zhang H, Tan CF, Mori F et al (2008) TDP-43-immunoreactive neuronal and glial inclusions in the neostriatum in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 115:115-122 (Pubitemid 350238670)